Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum
Clinical and Experimental Obstetrics & Gynecology · 07.01.2025 · 52 (1)
DOI: 10.31083/ceog26095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Obstetrics & Gynecology, online erschienen am 07.01.2025. Verfasst von Ying Wang und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Municipal Health Commission research project.
Abstract (Originalsprache)
Background
Placenta previa (PP) combined with placenta accreta spectrum (PAS) is a serious obstetric condition that increases the risk of maternal and fetal complications. Early diagnosis is therefore crucial for improving outcomes. The aim of this study was to evaluate the accuracy of magnetic resonance imaging (MRI) combined with three serological markers (alpha-fetoprotein [AFP], creatine kinase [CK], and soluble fms-like tyrosine kinase-1 [sFlt-1]) for the diagnosis of PP with PAS.
Methods
This retrospective study included 243 patients with suspected PP and PAS treated at two hospitals between August 2018 and August 2023. Patients were divided into two groups based on surgical and pathological findings: PP+PAS (+) and PP+PAS (–). The serum levels of AFP, CK, and sFlt-1 were measured, and optimal diagnostic thresholds were determined using receiver operating characteristic (ROC) curve analysis. The diagnostic performance of MRI, serological markers, and a combination of the two was compared with that of surgical pathology.
Results
Serum AFP, CK, and sFlt-1 levels were significantly higher in the PP+PAS (+) group compared to the PP+PAS (–) group. The optimal thresholds of AFP, CK, and sFlt-1 for the diagnosis of PP+PAS (+) were 58.49 U/mL, 168.25 U/mL, and 2.28 ng/mL, respectively. A combined diagnostic approach using MRI and serological markers showed good accuracy, with a Kappa coefficient of 0.850, indicating good agreement with surgical pathology.
Conclusions
Combining MRI with serological markers (AFP, CK, and sFlt-1) provides enhanced diagnostic accuracy for detecting PP with PAS as compared to either method alone. This approach can facilitate early diagnosis, improve clinical decision-making, and reduce the risks associated with surgical intervention.
Förderung
- Shanghai Municipal Health Commission research project
Zitieren
APA
Wang, Y., Hou, Z., Xia, B., Xie, X., & He, Y. (2025). Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum. Clinical and Experimental Obstetrics & Gynecology, 52(1). https://doi.org/10.31083/ceog26095
Vancouver
Wang Y, Hou Z, Xia B, Xie X, He Y. Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum. Clinical and Experimental Obstetrics & Gynecology. 2025;52(1). doi:10.31083/ceog26095
BibTeX
@article{Wang2025,
author = {Wang, Ying and Hou, Zhengdong and Xia, Bingqing and Xie, Xianjing and He, Ying},
title = {Magnetic Resonance Imaging Combined with Serological Markers Improves the Diagnosis of Placenta Previa with Placenta Accreta Spectrum},
journal = {Clinical and Experimental Obstetrics & Gynecology},
year = {2025},
volume = {52},
number = {1},
doi = {10.31083/ceog26095}
}
EUVIMED